Apyx Medical Corporation (APYX) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)
A side-by-side comparison of Apyx Medical Corporation and Corbus Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APYX
Apyx Medical Corporation
$2.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.85HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — APYX vs CRBP
growth of $100 · dividends reinvested · last 8yAPYX -59.8% (-10.8%/yr)CRBP -97.0% (-35.5%/yr)APYX compounded faster over this window
Log scale — wide-divergence pair
APYX CRBP
APYX vs CRBP: by the numbers
- •APYX is the larger company ($109M vs $108M market cap).
- •Both run net losses; CRBP's is the smaller (0.00% vs -14.78% net margin).
Metrics side by side
Valuation
| Metric | APYX | CRBP |
|---|---|---|
| P/S ratio | 1.87 | N/A |
| P/B ratio | 10.27 | 1.06 |
Profitability
| Metric | APYX | CRBP |
|---|---|---|
| Gross margin | 33.94% | 0.00% |
| Operating margin | -6.06% | 0.00% |
| Net margin | -14.78% | 0.00% |
| ROE | -80.97% | -99.67% |
| ROIC | -6.84% | -101.30% |
Growth (annualized)
| Metric | APYX | CRBP |
|---|---|---|
| Revenue CAGR (5Y) | 8.82% | N/A |
| Total return CAGR (5Y) | -28.10% | -28.32% |
Frequently asked
- How have APYX and CRBP total returns compared?
- Over the past 5 years, APYX delivered -28.10% and CRBP delivered -28.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.